|
Vaccine Detail
Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins |
Vaccine Information |
- Vaccine Name: Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins
- Target Pathogen: Hepatitis B virus
- Target Disease: Hepatitis B
- Vaccine Ontology ID: VO_0004353
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Duck
- Antigen: S protein from DHBV Australian strain (Triyatni et al., 1998)
- S
gene engineering:
- Type: DNA vaccine construction
- Description:
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0000130
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Ducks Response
- Vaccine Immune Response Type: VO_0000286
- Immune Response: The S-DNA vaccine was able to elicit humoral immune responses against DHBV surface proteins in ducks. In addition, The S-DNA vaccine induced high titers of anti-DHBs antibodies, and anti-S antibodies induced by the S-DNA construct were highly effective in neutralizing virus infectivity. (Triyatni et al., 1998).
- Efficacy: Vaccination of ducks with S DNA vaccines prevented the development of viremia following virus challenge. All ducks were challenged with a high-titer dose of DHBV virus. Preincubation of the virus with 5, 10, or, 20 μl of anti-S serum at 37°C for 1 hour prior to i.v. inoculation into 1-day-old ducklings completely prevented the development of viremia during a 4-week observation period in all of the ducks (Triyatni et al., 1998).
|
References |
Triyatni et al., 1998: Triyatni M, Jilbert AR, Qiao M, Miller DS, Burrell CJ. Protective efficacy of DNA vaccines against duck hepatitis B virus infection. Journal of virology. 1998; 72(1); 84-94. [PubMed: 9420203].
|
|